Navigation Links
Novel Hepatitis C Drug Holds Promise: FDA
Date:4/27/2011

/p>

The new drug was less effective for blacks than whites, the FDA said.

On Wednesday FDA reviewers were expected to study a similar drug, boceprevir, made by Merck & Co.

Telaprevir's cure rates appear to be better than boceprevir's, the AP reported.

On Thursday, the committee of outside experts will be asked for its comments and recommendations on telaprevir. The FDA is not required to follow the advice of its advisory panels, but it usually does so.

The U.S. Centers for Disease Control and Prevention estimated 17,000 new hepatitis C virus infections in the United States in 2007. Many people with the disease have no symptoms until it has caused liver damage, sometimes so severe that a liver transplant is needed.

Until the early 1990s, when testing of the nation's blood supply became routine, hepatitis C was often contracted from blood transfusions. Today it is most commonly associated with injection drug use. It is also transmitted through sexual contact with an infected person, the CDC said.

Earlier this year, a study from the Johns Hopkins School of Public Health called for greater efforts to reduce the population of hepatitis C-infected injection drug users. That study found that new cases of hepatitis C were decreasing only among younger injection drug users who had recently starting using the drugs.

More information

To learn more about hepatitis C, visit the U.S. National Library of Medicine.

-- HealthDay staff

SOURCES: U.S. Centers for Disease Control and Prevention; Associated Press


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. A potential novel drug-target for colorectal cancer treatment comes from the brain
2. Researchers identify novel pathophysiologic mechanism responsible for autoimmunity
3. Novel association between Parkinsons disease and prostate cancer
4. Novel immunotherapy drug receives FDA approval for the treatment of metastatic melanoma
5. Penn researchers uncover novel immune therapy for pancreatic cancer
6. Novel Treatment for Pancreatic Cancer Under Study
7. Novel approaches to bacterial caries management: An efficacious solution in view?
8. Novel strategies target health care-associated infections
9. Novel clinical trial aims to reduce recurrence of aggressive breast cancer
10. A novel prognostic marker for biliary atresia
11. Genome sequencing used to assess a novel form of Clostridium botulinum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... (PRWEB) May 05, 2015 ... honors Irene Taylor , Volunteer Executive Director ... a 2015-2016 inductee into its VIP Woman of ... prestigious distinction for leadership in business. NAPW is ... women, boasting more than 700,000 members and over ...
(Date:5/4/2015)... Garden City, NY (PRWEB) May 05, 2015 ... honors Gloria M. Betancourt as a ... Year Circle. She is recognized with this prestigious distinction ... networking organization exclusively for professional women, boasting more than ... "I'm pleased to present Gloria with this important honor," ...
(Date:5/4/2015)... London, UK (PRWEB) May 04, 2015 ... to witness a 7.7% CAGR. Currently, the European and ... the world, while the North American probiotic market lags ... of local population. , The North American probiotic ... of over 58%), followed by Canada and Mexico. The ...
(Date:5/4/2015)... Monkton, MD (PRWEB) May 04, 2015 ... affecting families for generations. While it can have ... in disabling and catastrophic events. Hereditary Hemorrhagic Telangiectasia ... of blood vessels that lack normal capillary connections between ... nose can cause frequent, severe nosebleeds, but may also ...
(Date:5/4/2015)... Milton Hershey School® has named J. Anthony Graves, ... recognizing his commitment to pediatric cancer research and the ... students. , “Dr. Graves is a tremendous example of ... a top-notch education, a nurturing environment, and the opportunity ... ’85, president of MHS. “He is applying the values ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Inducts Irene Taylor into its 2015-2016 VIP Woman of the Year Circle 2Health News:National Association of Professional Women Inducts Gloria Betancourt, Receptionist at Consulate Health Care, into its 2015-2016 VIP Woman of the Year Circle 2Health News:North America Probiotic Market to Increase by 2019, Announces MicroMarketMonitor in Its New Research Report Recently Published at MarketPublishers.com 2Health News:Frequent Nosebleeds Can Be a Sign of a Rare Undiagnosed Disease - Cure HHT 2Health News:Frequent Nosebleeds Can Be a Sign of a Rare Undiagnosed Disease - Cure HHT 3Health News:Milton Hershey School Names 2015 Alumnus of the Year 2
... Free from LTC Financial Partners, KIRKLAND, Wash., ... care,for an incapacitated parent or spouse, the impact ... estate or inheritance. And your loved,one,s daily needs ... *(PHOTO 72dpi: Send2Press.com/mediaboom/08-0227-JonasRoeser_72dpi.jpg), *(Photo Caption: LTC Senior ...
... Israel, Feb. 27 Shamir,Optical Industry Ltd. (Nasdaq: ... year end 2007 earnings results on Thursday, March 6, ... results at 9:00 A.M. EST,that morning., The conference ... To,listen live, please go to http://www.kcsa.com approximately ...
... 2008 -- A new study led by researchers at the ... diabetes who reported taking less insulin than prescribed had a ... complications than those who did not skip needed insulin shots. ... Care. , The study highlights the dangers of insulin restriction ...
... new article suggests that the United States government ... Cuba into a biomedical research institute dedicated to ... the open-access journal PLoS Neglected Tropical Diseases, Editor-in-Chief ... be in an optimal position to directly address ...
... Ventas, Inc. (NYSE:,VTR) ("Ventas" or the "Company") announced ... A. Cafaro, and Executive Vice,President and Chief Investment Officer, ... at the Citi 2008 Global Property CEO,Conference in Palm ... p.m.,Eastern Time., Those wishing to access the presentation ...
... Kansas City-based company connects, educates and entertains sports ... Sports enthusiasts have a new,online hotspot with Kansas ... have collaborated to produce AthletixNation.com, the premier,community for ... ultimate goal of AthletixNation.com is to have a ...
Cached Medicine News:Health News:Long Term Care Newsletter Helps Preserve Solvency & Sanity While Caring for Loved One 2Health News:Shamir Optical Industry Ltd. to Host Conference Call Announcing Fourth Quarter and Year End 2007 Earnings Results 2Health News:Joslin study finds restricting insulin doses increases mortality risk 2Health News:Joslin study finds restricting insulin doses increases mortality risk 3Health News:From detainee facility to health advocacy center: A new role for Guantanamo? 2Health News:AthletixNation.com Launches Sports Website and Community Programs 2
(Date:5/4/2015)... 2015   HeartWare International, Inc . (NASDAQ: HTWR ... technologies that are revolutionizing the treatment of advanced heart failure, ... is scheduled to present at the Bank of America Merrill ... on Thursday, May 14, 2015, at 10:00 a.m. ... the Company,s presentation at the conference will be available via ...
(Date:5/4/2015)... May 4, 2015  Isis Pharmaceuticals, Inc. (NASDAQ: ... with Bayer HealthCare (Bayer) to develop and commercialize ISIS-FXI ... terms of the agreement, Isis is eligible to receive ... immediate $100 million up-front payment and a $55 million ... 2 study in patients with compromised kidney function. Isis ...
(Date:5/4/2015)... DIEGO , May 4, 2015 ... oncology company focused on the clinical development of ... data showing mitochondria-specific effects of the Company,s investigational ... enhanced anti-tumor activity when combined with a tyrosine-kinase ... found ME-344 to be a potent inhibitor of ...
Breaking Medicine Technology:HeartWare Presentation At Bank Of America Merrill Lynch 2015 Health Care Conference To Be Webcast 2Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 2Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 3Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 4Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 5MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 2MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 3MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 4MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 5
... Inc. (NYSE Amex: ANX ) today announced that ... at the 10th Annual BIOInvestor Forum Conference on Wednesday, October ... Cliff Salon at the Palace Hotel in San Francisco. ... and slide presentation on the ADVENTRX Pharmaceuticals web site at ...
... Innocoll, Inc. announced it has entered into a ... for CollaGUARD surgical adhesion barrier for the prevention of ... Dr. Michael Myers, President and CEO stated "This ... an increasingly important and dynamic market for medical products ...
Cached Medicine Technology:Innocoll Enters Partnership With Pioneer Pharma in China for the Distribution of CollaGUARD 2Innocoll Enters Partnership With Pioneer Pharma in China for the Distribution of CollaGUARD 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: